Fish Oil 1000 mg

product on market Softgel Capsule AvPAK 🟢 Safety: 100/100
Brand: AvPAK
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel Capsule(s) Serving Size
50 Servings
Fat/Fatty Acid Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Calories from Fat
10 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
3 IU (10% DV)
✅ Within RDA (0.1× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 2.0100000000000002mg UL 1000mg
1000 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1000mg UL 3000mg

Other Ingredients

Gelatin Glycerin purified Water

Label Claims — Verification

❓ All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

⚠️ Warnings & Precautions

Contains Fish (sardine, mackerel, anchovy).

Additional Information

NDC 50268-308-15 50 Softgels (5 x 10) Unit Dose

Questions or Comments call 1-855-361-3993

Product Details

UPC / SKU 5026830815
DSLD Entry Date 2022-08-23
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand AvPAK
DSLD ID 271327
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI Cochrane
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI Cochrane
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI Cochrane
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
PubMed DOI Cochrane
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
PubMed DOI Cochrane
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
View all evidence for Omega 3 →

Compare Similar Products

Non-Fish Vegan Omega-3 DHA
Non-Fish Vegan Omega-3 DHA DEVA 100
Algal-900 DHA
Algal-900 DHA Spring Valley 100
Ultra Omega HoltraCeuticals 100
Pre & Post Natal DHA 100 mg Vitamin World 100
Triple Fish Oil 1000 mg Nature's Harmony 100
View all Omega 3 products →
Omega 3 research & evidence Best Omega 3 rankings All Omega 3 products More from AvPAK View on NIH DSLD →